Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...

Health Canada approved last month two  brand names for generic semaglutide products, Plosbrio  and  Poviztra, which contain ...

The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...

The price of semaglutide drugs could drop by more than 65% when generic versions of Ozempic and Wegovy hit shelves — possibly ...

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...

The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...

WASHINGTON, DC - APRIL 2: President Donald Trump signs an executive order imposing tariffs on imported goods during a "Make America Wealthy Again" trade announcement event in the Rose Garden at the ...

The country’s wavering stance on data exclusivity, which will allow corporations to hold a monopoly on drugs, risks global ...